Sahajanand Medical Technologies545001Quarterly results
Consolidated results for the 30 September, 2026
By ScoutQuest · · 1 min read
| Line item | Latest | Year ago | YoY | Prev qtr | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 37,341.01 | 29,947.09 | +24.7% | 35,166.85 | +6.2% |
| Total income | 37,564.59 | 30,181.42 | +24.5% | 35,433.35 | +6% |
| Profit before tax | 4,006.87 | 2,708.77 | +47.9% | 2,428.52 | +65% |
| Profit after tax | 2,646.92 | 2,090.77 | +26.6% | 1,509.23 | +75.4% |
| Total comprehensive income | 2,818.00 | 4,176.12 | −32.5% | 1,162.22 | +142% |
| Basic EPS | 2.63 | 2.00 | +31.5% | 1.48 | +77.7% |
- Profit after tax YoY growth
- +26.6%
- Period
- 30 September, 2026
Also decided at the meeting
- Approved investment by Sahajanand Medical Technologies Ireland Limited, wholly owned subsidiary, in SNP Medical Corp., a US based corporation registered in Delaware.
- Appointed M/s Amit Jaste & Associates, Company Secretaries, as Secretarial Auditor for five consecutive financial years FY 2026-27 to FY 2030-31, subject to shareholders' approval.
Auditor's review
Conclusion: Unmodified
- Other matter: interim results of 6 subsidiaries (total revenues Rs. 8,564.62 lakhs for the quarter) reviewed by other auditors; conclusion not modified in respect of this matter.
Notes to the results
- Equity shares listed on BSE and NSE on 23 October 2026 via IPO of 1,38,22,116 equity shares of Re. 1 each at Rs. 344 per share, entirely an offer for sale by selling shareholders.
- The Group operates in a single segment, "Cardiovascular Devices"; no separate segment disclosure made.
Consolidated results for the 30 September, 2026.
4,176.12 (Rs. in lacs)Total comprehensive income, year-ago quarter
Profit after tax, latest quarter2,646.92 (Rs. in lacs)
Profit after tax, quarter1,509.23 (Rs. in lacs)
Also from Sahajanand Medical Technologies
SMT Q2 FY27: record revenue, EBITDA and PAT in first results as a listed company
5 Nov 2026
GST recovery notice of ~Rs. 34.3 lakh over input tax credit; company says no material impact
4 Nov 2026
CRISIL upgrades Sahajanand Medical Technologies to CRISIL A-/Stable on Rs.300 crore bank facilities; subsidiary at CRISIL BBB+/Stable
4 Nov 2026
More numbers
- Total income, latest quarter37,564.59 (Rs. in lacs)
- Total income, year-ago quarter30,181.42 (Rs. in lacs)
- Total income, previous quarter35,433.35 (Rs. in lacs)
- Total comprehensive income, latest quarter2,818.00 (Rs. in lacs)
- Total comprehensive income, year-ago quarter4,176.12 (Rs. in lacs)
- Total comprehensive income, previous quarter1,162.22 (Rs. in lacs)
- Profit after tax, latest quarter2,646.92 (Rs. in lacs)
- Profit after tax, year-ago quarter2,090.77 (Rs. in lacs)
- Profit after tax, previous quarter1,509.23 (Rs. in lacs)
- Revenue from operations, latest quarter37,341.01 (Rs. in lacs)
- Revenue from operations, year-ago quarter29,947.09 (Rs. in lacs)
- Revenue from operations, previous quarter35,166.85 (Rs. in lacs)
- Profit before tax, latest quarter4,006.87 (Rs. in lacs)
- Profit before tax, year-ago quarter2,708.77 (Rs. in lacs)
- Profit before tax, previous quarter2,428.52 (Rs. in lacs)
Source: BSE · 5 Nov 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.